Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study

ObjectivesTo monitor the safety and utilisation of AZD1222 under real-world use in the UK.DesignA non-interventional post-authorisation active surveillance study.SettingVaccination sites in the UK.ParticipantsA total of 17 945 participants were eligible and provided consent to participate in the stu...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMJ open Ročník 15; číslo 5; s. e093366
Hlavní autori:	Evans, Alison, Roy, Debabrata, Davies, Miranda, Dhanda, Sandeep, Morris, Denise, Aurelius, Taylor, Lane, Samantha, Fry, Catherine, Shakir, Saad
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England British Medical Journal Publishing Group 02.05.2025 BMJ Publishing Group LTD BMJ Publishing Group
Predmet:	Adult Aged Breastfeeding & lactation ChAdOx1 nCoV-19 - adverse effects Clinical medicine COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - adverse effects Drug Utilization Epidemiology Family physicians Female Headache - chemically induced Headache - epidemiology Humans Immunization Male Middle Aged Non-pharmacological intervention Original Research Pandemics Product Surveillance, Postmarketing Public health Regulatory agencies Safety SARS-CoV-2 Surveillance United Kingdom - epidemiology Vaccination United Kingdom United Kingdom > UK Drug Utilization Vaccination Safety
ISSN:	2044-6055, 2044-6055
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!